Member Info for JohnHenry

Love ya 2 PP saying what im seeing. i guess im seeing correct at the Mo.

Retail investors moving funds out of GDR and into NCYT.

Grimshady im merely pointing out how the market is valuing Covid testing stocks. Like a stage that NCYT went through no matter what the announcement the market wanted numbers when they got numbers that’s when the mkt started to value and support. GDR is 9 months behind NCYT. GDR valuation at present is speculative and about hope as they have nothing underpinning the SP such as cash and growing revenues.

It understanding how the dynamics of the market has changed in Testing stocks.

NCYT is moving forward why ? because Sales and Revenue are increasing. Hence cash pile is increasing.

GDRs SP will move forward when sales materialise and are seen to be growing.

Aimho

Covid testing stocks have had the speculation phase, Know its all about Sales and Revenue.

At present GDR have nothing so theres nothing solid underpinning the Price.

Theres going to be a rush to get back in for those that sold wanting to buy back in and hold.

a seller. L2 has flipped quite quickly.

Jimzi im guessing not through IG

Looking like the Challenge study news is being discounted back to 15.5-16p

L2 very weak 15.5p BID coming imho

I share you thoughts deepjoy, ive personnally had enough of Friel constantly putting a downer on the SP

Maybe a decent businessman but his gobs a liability when it comes to SP levels.

Friel today has surprisingly kick the S out of the momentum, we have had months of institutional selling a brief ray of sunshine and he slams the door on the PA.
May even drift back to 15p tomorrow.

has had the desired effect 16.5p. News is also in the price.

Friel really needs to leave the SP to market forces.

Russky thats absolute rubbish i suggest you check out companies that have dual listings on the Nasdaq.

16.5p looks odds on to be tested, Speeding Ticket has certainly brought out the sellers. Without Ticket 20p plus would have been stamped imho. Im guessing the Nomad insisted.

Really on an order driven market, MMs are hardly involved.

Peter there was always a slight doubt that Human C S may not be get approval, todays news has pretty much lifted that doubt.

Hardly a speculative report from the FT, if from one of the daily comics then i would agree.

18-20p range close 20p

118-120p